Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest press releases The press releases are intended for media and financial analysts Press release 26 Feb 2026 Strong Execution Fueling Sustained Company Growth Read More Press release 4 Feb 2026 UCB showcases three-year hidradenitis suppurativa data at EHSF: BIMZELX[®]▼(bimekizumab) achieved... Read More Press release 30 Jan 2026 KYGEVVI[®] (doxecitine and doxribtimine) recommended for approval in the European Union as treatment... Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Press release 4 Feb 2026 UCB showcases three-year hidradenitis suppurativa data at EHSF: BIMZELX[®]▼(bimekizumab) achieved... Read More
Press release 30 Jan 2026 KYGEVVI[®] (doxecitine and doxribtimine) recommended for approval in the European Union as treatment... Read More
